GlassScriptPhysician profile
Lucy Y Zhang
NPI 1326304809
$3,388.42
in general payments reported to CMS, 2019-2025
25 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $245 · 2021: $350 · 2022: $250 · 2023: $302 · 2024: $568 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.12 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $657.97 | 2019-2025 | Clareon, Rocklatan, Argos |
| Bausch & Lomb Americas INC. | $373.70 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Dompe US, INC. | $350.72 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $225.12 | 2020-2022 | |
| Biotissue Holdings INC. | $204.84 | 2019-2025 | |
| Allergan, INC. | $176.33 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $169.29 | 2023-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.22 | 2019-2020 | |
| Amgen INC. | $137.19 | 2024-2025 | Tepezza |
| Abbvie INC. | $136.60 | 2022-2025 | |
| Horizon Therapeutics Plc | $136.53 | 2021-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $136.00 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $125.14 | 2024-2025 | Vevye, Iheezo |
| Oyster Point Pharma, INC. | $62.45 | 2023-2024 | Tyrvaya |
| Omeros Corporation | $53.53 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $44.64 | 2021 | |
| Sun Pharmaceutical Industries INC. | $42.45 | 2023 | Cequa |
| Rxsight INC | $39.95 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $37.46 | 2023-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Thea Pharma INC. | $24.44 | 2025 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $19.36 | 2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Carl Zeiss Meditec USA, INC. | $19.23 | 2022 | |
| Eyepoint US, INC. | $18.95 | 2020 | |
| Sight Sciences, INC. | $15.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.